These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20159864)

  • 1. Studies probe medication use in pregnancy.
    Kuehn BM
    JAMA; 2010 Feb; 303(7):601. PubMed ID: 20159864
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug use during pregnancy: are risk classifications more dangerous than the drugs?
    Bianca S
    Lancet; 2003 Jul; 362(9380):329. PubMed ID: 12892970
    [No Abstract]   [Full Text] [Related]  

  • 3. [When pregnant patients become ill].
    Kreuz DG
    Kinderkrankenschwester; 2011 Nov; 30(11):469. PubMed ID: 22165518
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy.
    Haas DM; Gallauresi B; Shields K; Zeitlin D; Clark SM; Hebert MF; Ren Z; Nallani SC; Meslin EM; Feibus KB; Koren G; Goebel WS; Easterling T; Denne SC; Flockhart DA; Renbarger JL
    Clin Transl Sci; 2011 Jun; 4(3):204-9. PubMed ID: 21707952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is this drug safe in pregnancy?
    Webster WS; Freeman JA
    Reprod Toxicol; 2001; 15(6):619-29. PubMed ID: 11738515
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pregnancy and drugs].
    Hiramatsu Y
    Arerugi; 2014 Feb; 63(1):6-13. PubMed ID: 24647418
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA ponders approaches to curbing adverse effects of drug used against cystic acne.
    Marwick C
    JAMA; 1988 Jun; 259(22):3225. PubMed ID: 2967382
    [No Abstract]   [Full Text] [Related]  

  • 8. Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy.
    Wong JW; Heller MM; Murase JE
    Dermatol Online J; 2012 Oct; 18(10):15. PubMed ID: 23122022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
    Murase JE; Heller MM; Butler DC
    J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing for the pregnant patient.
    Mehta N; Chen K; Powrie RO
    Cleve Clin J Med; 2014 Jun; 81(6):367-72. PubMed ID: 24891538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
    Tassinari MS; Sahin L; Yao LP
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Safety of Common Medications Used During Pregnancy.
    Dude C; Jamieson DJ
    JAMA; 2021 Dec; 326(23):2421-2422. PubMed ID: 34932091
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?
    Law R; Bozzo P; Koren G; Einarson A
    Can Fam Physician; 2010 Mar; 56(3):239-41. PubMed ID: 20228306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Information on the risk of drugs in pregnancy: New regulation of the Food and Drug Administration].
    García Caeiro ÁL; Rey Liste MT; Ventosa Rial JJ; Alonso Fachado A
    Aten Primaria; 2017 Dec; 49(10):622-623. PubMed ID: 28844480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Consequences of drugs administered to the mother for the fetus and the newborn infant].
    Kaufmann HJ
    Monatsschr Kinderheilkd (1902); 1967 Apr; 115(4):154-8. PubMed ID: 5592499
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Are sex hormones teratogenic?
    Lancet; 1974 Dec; 2(7895):1489-90. PubMed ID: 4140400
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of pregnancy outcome risk rates after exposure to an intervention.
    Goldstein DJ; Sundell KL; DeBrota DJ; Offen WW
    Clin Pharmacol Ther; 2001 Jan; 69(1):7-13. PubMed ID: 11180033
    [No Abstract]   [Full Text] [Related]  

  • 18. Collection and analysis of drug safety data in pregnancy.
    Moretti M
    Can J Clin Pharmacol; 2007; 14(1):e34-6. PubMed ID: 17213508
    [No Abstract]   [Full Text] [Related]  

  • 19. Bendectin and birth defects: hopefully, the final chapter.
    Brent R
    Birth Defects Res A Clin Mol Teratol; 2003 Feb; 67(2):79-87. PubMed ID: 12769503
    [No Abstract]   [Full Text] [Related]  

  • 20. Medications in pregnancy and lactation.
    McCarter-Spaulding DE
    MCN Am J Matern Child Nurs; 2005; 30(1):10-7; quiz 18-9. PubMed ID: 15622140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.